Fondaparinux indications

Indications
Fondaparinux sodium (Arixtra) Injection is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism:


 * in patients undergoing hip fracture surgery, including extended prophylaxis;
 * in patients undergoing hip replacement surgery;
 * in patients undergoing knee replacement surgery;
 * in patients undergoing abdominal surgery who are at risk for thromboembolic complications.

Fondaparinux sodium (Arixtra) Injection is indicated for:


 * the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium, and
 * the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital.